Literature DB >> 519876

Cimetidine induced prolactin (PRL) release in thyroid disease.

C Macaron, M Kyncl, S P Singh.   

Abstract

Effects of acute intravenous administration of cimetidine on serum levels or PRL, TSH, LH and FSH were investigated in six healthy euthyroid, five hypothyroid and five hyperthyroid patients. Cimetidine failed to alter serum TSH levels in the hypothyroid patients. There was no change in LH and FSH levels except in two euthyroid subjects in whom significant rise in LH occurred. However, in all subjects, whether euthyroid, hypo- or hyperthyroid, the serum PRL concentration increased two to three fold above basal levels. The peak levels of serum PRL occurred at 15 min following the drug administration. The response was not blunted in the older age group. We conclude that unlike the TRH-mediated PRL release, the cimetidine-induced PRL release is independent of the levels of thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519876     DOI: 10.1111/j.1365-2265.1979.tb03088.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  Inhibition of cimetidine-induced hyperprolactinemia by pretreatment with metergoline.

Authors:  M Iodice; G Lombardi; A P Tommaselli; R Rossi; M Minozzi
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

2.  The effects of ranitidine on pituitary-thyroid function.

Authors:  K R Hine; J S Harrop; M R Hopton; G K Holmes; H L Matthews
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.